Corretion to: European Radiology (2020) 30:175–185

https://doi.org/10.1007/s00330-019-06374-7

On request from the Editors, the authors would like to clarify the following:

the patient cohorts in the publications “No evidence of improved efficacy of covered stents over uncovered stents in percutaneous palliation of malignant hilar biliary obstruction: results of a prospective randomized trial” (Dhondt et al, https://doi.org/10.1007/s00330-019-06374-7) and “No Advantage of Expanded Polytetrafluoroethylene and Fluorinated Ethylene Propylene–Covered Stents over Uncovered Nitinol Stents for Percutaneous Palliation of Malignant Infrahilar Biliary Obstruction: Results of a Single-Center Prospective Randomized Trial” (Dhondt et al, https://doi.org/10.1016/j.jvir.2019.07.013) have no overlaps.

Both were recruited from the hospital’s cohort of all tumour patients referred for percutaneous transhepatic stenting who were not amenable by ERCP. In both publications, this was explained in the patients’ recruitment flow chart.